A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device

Inclusion Criteria

• •A. Patient has signed an IRB approved, study specific Informed Patient Consent Form.
• •B. Patient is a male or non-pregnant female age 45 years or younger at time of study device implantation.
• •C. Patient is a candidate for repair of one longitudinal vertical tear (bucket handle) fully located in the red-white (vascular-avascular) zone of the meniscus (3-5 mm from the synovial-meniscus junction) or repair of one longitudinal vertical tear (bucket handle) primarily located in the red-white zone of the meniscus, but partially (\< 30% of total length) extending into the red zone (\< 3 mm from the synovial-meniscus junction) and/or into the white zone (\> 5 mm from the synovial-meniscus junction).
• •D. Patient does not require more than three BioDuct® Meniscal Repair Devices for the meniscal tear.
• •E. Patient requires suture only for fixation at the site where the study device will be used.
• •F. Patient is willing and able to comply with postoperative scheduled MRI and clinical evaluations and rehabilitation.